The Nutshell

» disease/medicine and cell & molecular biology

Daily News Roundup

Most Recent

image: Week in Review

Week in Review

By | March 15, 2013

Disgruntled Nobel loser sues; brain trauma researchers search for biomarker of a chronic condition; receptor for novel coronavirus found; the rise of transcriptomics; and ethical oversight of participant-led research

0 Comments

image: Bee Venom for HIV Prevention

Bee Venom for HIV Prevention

By | March 12, 2013

Nanoparticles coated with a toxin found in bee venom can destroy HIV while leaving surrounding cells intact.

2 Comments

image: Lucrative Prize for Life Scientists

Lucrative Prize for Life Scientists

By | February 21, 2013

Three Silicon Valley entrepreneurs are offering $3 million to scientists demonstrating excellence in biology and medical research.

1 Comment

image: Stem Cell Trial Nearly Approved

Stem Cell Trial Nearly Approved

By | February 15, 2013

The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.

0 Comments

image: New TB Vaccine Fails Trial

New TB Vaccine Fails Trial

By | February 4, 2013

One of the most advanced tuberculosis vaccines has failed to protect infants from getting the disease in a clinical trial, but it may be effective in adults.

1 Comment

image: Stem-Cell Clinic Moves to Mexico

Stem-Cell Clinic Moves to Mexico

By | February 1, 2013

A company offering experimental stem-cell treatments will carry out its procedures in Mexico after the FDA warned that it would need approval to operate in the U.S.  

0 Comments

image: Stem Cells Not Rejected

Stem Cells Not Rejected

By | January 25, 2013

Researchers uncover more evidence that reprogrammed stem cells are not attacked by the immune system, suggesting they may one day serve as effective therapies.

1 Comment

image: Bird Flu Research to Resume

Bird Flu Research to Resume

By | January 24, 2013

After a year-long voluntary moratorium to discuss regulations and safety measures, scientists are set to resume controversial H5N1 research.

1 Comment

image: Some Insurers Protected by GINA

Some Insurers Protected by GINA

By | January 23, 2013

Long-term, life, and disability insurers may still be able to deny coverage to patients with a genetic disease, under current nondiscrimination legislation.

2 Comments

image: First Recombinant Flu Vaccine

First Recombinant Flu Vaccine

By | January 21, 2013

The US Food and Drug Administration approves the first flu vaccine made from recombinant proteins rather than a weakened virus.

1 Comment

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech